SG11201704430SA - Preventive and/or therapeutic agent of immune disease - Google Patents

Preventive and/or therapeutic agent of immune disease

Info

Publication number
SG11201704430SA
SG11201704430SA SG11201704430SA SG11201704430SA SG11201704430SA SG 11201704430S A SG11201704430S A SG 11201704430SA SG 11201704430S A SG11201704430S A SG 11201704430SA SG 11201704430S A SG11201704430S A SG 11201704430SA SG 11201704430S A SG11201704430S A SG 11201704430SA
Authority
SG
Singapore
Prior art keywords
preventive
therapeutic agent
immune disease
immune
disease
Prior art date
Application number
SG11201704430SA
Other languages
English (en)
Inventor
Fumihito Hosoi
Yoshinori Nakachi
Daisuke Kajiwara
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of SG11201704430SA publication Critical patent/SG11201704430SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
SG11201704430SA 2015-01-30 2016-01-29 Preventive and/or therapeutic agent of immune disease SG11201704430SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015017386 2015-01-30
PCT/JP2016/052732 WO2016121953A1 (ja) 2015-01-30 2016-01-29 免疫疾患の予防及び／又は治療剤

Publications (1)

Publication Number Publication Date
SG11201704430SA true SG11201704430SA (en) 2017-08-30

Family

ID=56543555

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201704430SA SG11201704430SA (en) 2015-01-30 2016-01-29 Preventive and/or therapeutic agent of immune disease

Country Status (21)

Country Link
US (1) US9782412B2 (ja)
EP (1) EP3120852B1 (ja)
JP (1) JP6093485B2 (ja)
KR (1) KR101858421B1 (ja)
CN (2) CN107206001B (ja)
AU (1) AU2016213030B2 (ja)
BR (1) BR112017016278B1 (ja)
CA (1) CA2975372C (ja)
DK (1) DK3120852T3 (ja)
ES (1) ES2734364T3 (ja)
HU (1) HUE045532T2 (ja)
MX (1) MX2017009863A (ja)
MY (1) MY197518A (ja)
PH (1) PH12017501336A1 (ja)
PL (1) PL3120852T3 (ja)
PT (1) PT3120852T (ja)
RU (1) RU2705154C2 (ja)
SG (1) SG11201704430SA (ja)
TR (1) TR201910158T4 (ja)
TW (1) TWI638817B (ja)
WO (1) WO2016121953A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2974335C (en) 2015-01-30 2019-04-09 Taiho Pharmaceutical Co., Ltd. Novel salt of fused pyrimidine compound and crystal thereof
US20230064254A1 (en) * 2019-12-19 2023-03-02 Taiho Pharmaceutical Co., Ltd. Therapeutic agent containing fused pyrimidine compound as active ingredient
CN112209894B (zh) * 2020-10-23 2023-06-06 贵州医科大学 5-芳基取代2-氨基苯并恶唑类衍生物、制备方法及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5237108B2 (ja) * 2005-12-08 2013-07-17 アボット・ラボラトリーズ タンパク質キナーゼ阻害薬としての９員ヘテロ二環式化合物
CA2663279C (en) * 2006-09-13 2016-05-17 Takeda Pharmaceutical Company Limited Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile for treating diabetes, cancer, autoimmune disorders and hiv infection
CA2668286C (en) * 2006-11-03 2014-09-16 Pharmacyclics, Inc. Bruton's tyrosine kinase activity probe and method of using
JP2009235057A (ja) * 2007-10-31 2009-10-15 Santen Pharmaceut Co Ltd 血管新生阻害活性を有する新規インドール誘導体
BRPI0914682B8 (pt) 2008-06-27 2021-05-25 Avila Therapeutics Inc compostos de heteroarila e composições compreendendo os referidos compostos
US8338439B2 (en) 2008-06-27 2012-12-25 Celgene Avilomics Research, Inc. 2,4-disubstituted pyrimidines useful as kinase inhibitors
WO2013010136A2 (en) * 2011-07-13 2013-01-17 Pharmacyclics, Inc. Inhibitors of bruton's tyrosine kinase
SG2014009286A (en) 2012-01-19 2014-04-28 Taiho Pharmaceutical Co Ltd 3,5-disubstituted alkynylbenzene compound and salt thereof
JP2015526520A (ja) * 2012-08-31 2015-09-10 プリンシピア バイオファーマ インコーポレイテッド Ｉｔｋ阻害剤としてのベンズイミダゾール誘導体
NO2947086T3 (ja) 2013-08-12 2018-06-02

Also Published As

Publication number Publication date
DK3120852T3 (da) 2019-07-29
US20170042900A1 (en) 2017-02-16
PH12017501336A1 (en) 2017-12-11
EP3120852A1 (en) 2017-01-25
TW201632526A (zh) 2016-09-16
JP6093485B2 (ja) 2017-03-08
CN107206001B (zh) 2021-09-28
TR201910158T4 (tr) 2019-07-22
MX2017009863A (es) 2017-11-15
PT3120852T (pt) 2019-07-16
BR112017016278A2 (ja) 2018-03-27
MY197518A (en) 2023-06-19
HUE045532T2 (hu) 2020-01-28
PL3120852T3 (pl) 2019-09-30
CN107206001A (zh) 2017-09-26
JPWO2016121953A1 (ja) 2017-04-27
KR20170083640A (ko) 2017-07-18
WO2016121953A1 (ja) 2016-08-04
CA2975372C (en) 2020-01-14
CN113768935A (zh) 2021-12-10
AU2016213030A1 (en) 2017-06-22
BR112017016278B1 (pt) 2022-05-10
CA2975372A1 (en) 2016-08-04
RU2705154C2 (ru) 2019-11-05
RU2017127126A (ru) 2019-03-01
KR101858421B1 (ko) 2018-05-15
AU2016213030B2 (en) 2019-01-31
ES2734364T3 (es) 2019-12-05
EP3120852B1 (en) 2019-05-01
TWI638817B (zh) 2018-10-21
RU2017127126A3 (ja) 2019-03-01
US9782412B2 (en) 2017-10-10
EP3120852A4 (en) 2017-05-24

Similar Documents

Publication Publication Date Title
IL277648A (en) Medical microbiota for the treatment and/or prevention of food allergy
HK1252873A1 (zh) 用於癌症治療和預防的疫苗
IL258854A (en) Preparations containing cannabidiol and secondary medicinal agents for cancer treatment
ZA201902090B (en) Combination treatments comprising administration of imidazopyrazinones
IL266047A (en) Methods and preparations for the treatment of Fabry disease
SG10201402819WA (en) Composition for prevention and treatment of joint pain and the method of preparation thereof
IL247368A0 (en) Diagnostic and therapeutic uses of exosomes
IL266486A (en) Pharmaceutical preparations and methods for cancer treatment
HK1246689A1 (zh) 溴莫尼定和噻嗎洛爾的固定劑量組合
IL259710A (en) Preparations and methods for the treatment of Davidson's disease (microvillus inclusion disease) and related diseases
PL3081228T3 (pl) Iryzyna do leczenia i zapobiegania osteoporozie
GB201504387D0 (en) Materials and methods for the treatment of vascular disease
HK1258056A1 (zh) 治療性化合物和其使用方法
SG11201704430SA (en) Preventive and/or therapeutic agent of immune disease
ZA201906964B (en) Prevention and/or treatment of inflammatory skin disease
GB201522329D0 (en) Use of adjuvants for the prevention and/or treatment of autoimmune diseases
PL3137097T3 (pl) Leczenie i profilaktyka choroby Alzheimera (AD)
EP3377062C0 (en) AMINONAPHHOQUINONE COMPOUNDS FOR THE TREATMENT AND/OR PREVENTION OF FIBROSIS DISEASES
LT3137093T (lt) Alzheimerio ligos (ad) gydymas ir prevencija
PT3137094T (pt) Tratamento e prevenção da doença de alzheimer (da)
IL257689A (en) Pharmacological preparations and methods for the treatment of diseases associated with hypoxia
IL259383A (en) A compound for use in the prevention and treatment of neurodegenerative diseases
HK1246271A1 (zh) 用於合成羥基-三甘油酯的方法及其用於預防和治療疾病的用途
GB201621398D0 (en) Treatment of emt-associated disease
GB201522828D0 (en) Prevention and treatment of glaucoma